Evidence map›Paper›PMID 31883330›Full record

Trial reportEuropean heart journal2020

Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain.

Kenneth Mangion, Philip D Adamson, Michelle C Williams, Amanda Hunter, Tania Pawade, Anoop S V Shah, Stephanie Lewis, Nicholas A Boon, Marcus Flather, John Forbes and 7 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Reappraising Ischemic Heart Disease in Women.Reviews in cardiovascular medicine · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kenneth MangionBritish Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Philip D AdamsonBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Michelle C WilliamsBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Amanda HunterBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Tania PawadeBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Anoop S V ShahBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Stephanie LewisBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Nicholas A BoonBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Marcus FlatherNorwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.
John ForbesGraduate Entry School, University of Limerick, Limerick, St Nessan's Rd, Dooradoyle, Co. Limerick, V94 F858, Ireland.
Scott McLeanNational Health Service, Hayfield House, Hayfield Rd, Kirkcaldy KY2 5AH, Fife, UK.
Giles RoditiBritish Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Edwin J R van BeekBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
Adam D TimmisWilliam Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.
David E NewbyBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SA, UK.
David A McAllisterInstitute of Health and Wellbeing, University of Glasgow, University Ave, Glasgow G12 8QQ, UK.
Colin BerryBritish Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.

Funding

British Heart Foundation CH09/002British Heart Foundation FS/15/54/31639British Heart Foundation FS/16/19/31982British Heart Foundation RE/13/3/30183British Heart Foundation RE/18/6134217British Heart Foundation RG/16/10/32375Medical Research Council G0701127Wellcome TrustWellcome Trust WT103782AIA
6 · The paper itself

Abstract

aimsThe relative benefits of computed tomography coronary angiography (CTCA)-guided management in women and men with suspected angina due to coronary heart disease (CHD) are uncertain. METHODS AND

resultsIn this post hoc analysis of an open-label parallel-group multicentre trial, we recruited 4146 patients referred for assessment of suspected angina from 12 cardiology clinics across the UK. We randomly assigned (1:1) participants to standard care alone or standard care plus CTCA. Fewer women had typical chest pain symptoms (n = 582, 32.0%) when compared with men (n = 880, 37.9%; P < 0.001). Amongst the CTCA-guided group, more women had normal coronary arteries [386 (49.6%) vs. 263 (26.2%)] and less obstructive CHD [105 (11.5%) vs. 347 (29.8%)]. A CTCA-guided strategy resulted in more women than men being reclassified as not having CHD {19.2% vs. 13.1%; absolute risk difference, 5.7 [95% confidence interval (CI): 2.7-8.7, P < 0.001]} or having angina due to CHD [15.0% vs. 9.0%; absolute risk difference, 5.6 (2.3-8.9, P = 0.001)]. After a median of 4.8 years follow-up, CTCA-guided management was associated with similar reductions in the risk of CHD death or non-fatal myocardial infarction in women [hazard ratio (HR) 0.50, 95% CI 0.24-1.04], and men (HR 0.63, 95% CI 0.42-0.95; Pinteraction = 0.572).

conclusionFollowing the addition of CTCA, women were more likely to be found to have normal coronary arteries than men. This led to more women being reclassified as not having CHD, resulting in more downstream tests and treatments being cancelled. There were similar prognostic benefits of CTCA for women and men.

Indexed as

Coronary Artery DiseaseCoronary DiseaseAngina PectorisChest PainComputed Tomography AngiographyCoronary AngiographyFemaleHumansMalePredictive Value of TestsAnginaCoronary heart diseaseCTCACT coronary angiographyGender

Identifiers

PMID31883330
PMCPMC7109601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.